시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
전엑솜 시퀀스 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 워크플로우별, 용도별, 최종 용도별, 지역별 - 산업 예측)2025-2032년)
Whole Exome Sequencing Market Size, Share, Growth Analysis, By Product (Instruments, Consumables), By Technology (Sequencing by Synthesis, ION Semiconductor Sequencing), By Workflow, By Application, By End-use, By Region - Industry Forecast 2025-2032
상품코드 : 1630647
리서치사 : SkyQuest
발행일 : 2025년 01월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,692,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,998,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,304,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 전엑솜 시퀀스 시장 규모는 2023년에 4억 9,688만 달러에 달하며, 2024년 5억 8,334만 달러에서 2032년에는 21억 506만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 17.4%로 성장할 전망입니다.

전체 엑솜 시퀀싱 시장은 유전성 질환 및 만성질환의 조기 및 정확한 검출을 촉진하는 기술 발전으로 인해 강력한 성장세를 보이고 있습니다. 연구 및 진단 분야의 새로운 용도는 비용 절감과 함께 맞춤형 의료 솔루션에 대한 수요를 크게 증가시키고 있습니다. 의료 전문가들은 현재 전체 엑솜 시퀀싱을 활용하여 유전적 변이를 식별하고, 환자 개개인에 맞는 치료법을 개발하여 임상 결과를 개선하고 있습니다. BGI Genomics와 중국의 의료 서비스 프로바이더와 BGI Genomics의 제휴와 같은 협업은 이러한 서비스가 점점 더 쉽게 이용할 수 있게된 것을 증명합니다. 특히 Natera의 FDA 지정 혁신 기기인 Signatera와 같은 혁신적인 기술은 암 진단 및 모니터링에 있으며, 엑솜 시퀀싱의 혁신적 잠재력을 보여주고 있습니다. 개인맞춤형 의료가 주도하는 가운데, 시장은 새로운 진단법과 기술로 지속적으로 확대될 준비가 되어 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

전엑솜 시퀀스 시장 규모 : 제품별

전엑솜 시퀀스 시장 규모 : 기술별

전엑솜 시퀀스 시장 규모 : 워크플로우별

전엑솜 시퀀스 시장 규모 : 용도별

전엑솜 시퀀스 시장 규모 : 최종 용도별

전엑솜 시퀀스 시장 규모

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Whole Exome Sequencing Market size was valued at USD 496.88 million in 2023 and is poised to grow from USD 583.34 million in 2024 to USD 2105.06 million by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The market for whole exome sequencing is experiencing robust growth driven by advancements in technology that facilitate early and accurate detection of genetic and chronic diseases. New applications in research and diagnostics, coupled with decreasing costs, have significantly increased demand for personalized medical solutions. Medical professionals now leverage whole exome sequencing to identify genetic variations and tailor treatments to individual patients, enhancing clinical outcomes. Collaborations, such as the partnership between a Chinese healthcare provider and BGI Genomics, underscore the rising accessibility of these services. Notably, innovations like Natera's FDA-designated breakthrough device, Signatera, exemplify the transformative potential of exome sequencing in cancer diagnosis and monitoring. As personalized medicine gains traction, the market is poised for continued expansion with emerging diagnostics and technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segmental Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A key factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans that align with the patient's specific genetic profile and risk of disease. This bespoke approach not only enhances the efficacy of therapies but also promotes better patient outcomes. The continued advancements in sequencing technologies and data analysis capabilities have made whole exome sequencing increasingly accessible and cost-effective, thus encouraging its implementation in clinical environments. As the emphasis on personalized healthcare continues to grow, so does the demand for whole exome sequencing, shaping the future landscape of medical treatment.

Restraints in the Global Whole Exome Sequencing Market

A notable constraint impacting the global whole exome sequencing market is the challenges tied to data complexity and interpretation. The considerable volume of genomic data produced presents significant difficulties in analysis, necessitating extensive expertise and time. Ensuring that the results are both accurate and reliable is essential for making sound medical decisions. The reliance on advanced bioinformatics tools and qualified personnel for effective data handling and interpretation limits the broader adoption of whole exome sequencing. Consequently, this factor restricts its accessibility and feasibility in various healthcare environments, hindering the implementation of this innovative technology.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is witnessing a significant trend driven by the integration of artificial intelligence (AI) and machine learning (ML) algorithms into data analysis and interpretation processes. This innovative approach is transforming how vast amounts of genomic data generated through whole exome sequencing are processed, enabling more efficient identification of genetic variations and disease associations. By automating data handling, AI and ML improve accuracy and efficiency in genomic analysis, thus facilitating faster, precise diagnoses and personalized treatment strategies. As these technologies continue to evolve, they are set to revolutionize genomic medicine, underscoring their critical role in shaping the future of healthcare.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Whole Exome Sequencing Market Size by Product & CAGR (2025-2032)

Global Whole Exome Sequencing Market Size by Technology & CAGR (2025-2032)

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2025-2032)

Global Whole Exome Sequencing Market Size by Application & CAGR (2025-2032)

Global Whole Exome Sequencing Market Size by End-use & CAGR (2025-2032)

Global Whole Exome Sequencing Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기